Results 71 to 80 of about 149 (130)

IL‐25 Enhances B Cell Responses in Type 2 Inflammation Through IL‐17RB Receptor

Allergy, Volume 80, Issue 4, Page 965-975, April 2025.
Human B cells express IL‐17RB under IgE inducing conditions (anti‐CD40 + IL‐4) and respond to IL‐25 with enhanced antibody production, particularly IgE. ScRNA‐seq revealed that IL‐17RB+ B cells have a distinct transcriptional profile compared to IL‐17RB‐B cells.
Semah Abdu, Jiao Xia, Huihui Yuan, Tiak Ju Tan, Janice A. Layhadi, Mohamed H. Shamji, Andrew N. J. McKenzie, Nora Haloob, Claire Hopkins, Grzegorz Woszczek, Stephen J. Till   +10 more
wiley   +1 more source

An algorithm for the diagnosis and treatment of nonsteroidal antiinflammatory drugs hypersensitivity, 2024 update

Allergy, Volume 80, Issue 4, Page 1183-1186, April 2025.
Inmaculada Doña, Rocío Sáenz de Santa María, Esther María Moreno, Joan Bartra, María José Torres   +4 more
wiley   +1 more source

Indoor Mycotoxin Exposure on Atopic Dermatitis in Companion Dogs

Allergy, Volume 80, Issue 4, Page 1124-1126, April 2025.
Songju Oh, Jungwoo Han, Ha‐Jung Kim
wiley   +1 more source

Real‐World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma (IRSA)

Allergy, Volume 80, Issue 4, Page 1119-1123, April 2025.
M. Beatrice Bilò, Matteo Martini, Leonardo Antonicelli, Fausto de Michele, Adriano Vaghi, Antonino Musarra, Claudio Micheletto   +6 more
wiley   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

Allergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, Sébastien Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Pinaki Biswas, Haiyun Fan, Justine Alderfer, Melissa Watkins, Herwig Koppensteiner   +13 more
wiley   +1 more source

Food‐Induced Anaphylaxis Reactions at School: A Room for Improvement

Allergy, Volume 80, Issue 4, Page 1132-1136, April 2025.
Guillaume Pouessel, Amandine Divaret‐Chauveau, Pascale Beaumont, Eléna Bradatan, Pascale Dumond, Yasemin Karaca‐Altintas, Carine Metz‐Favre, Delphine Delalande, Anne‐Karine Correard, Sélina Tscheiller, Xavier Van der Brempt, Camille Braun, Dominique Sabouraud‐Leclerc   +12 more
wiley   +1 more source

Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto's Thyroiditis Are Risk Factors for Early‐Onset, Severe and Prolonged Alopecia Areata

Allergy, Volume 80, Issue 4, Page 1158-1161, April 2025.
Annika Friedrich, Marie‐Therese Schmitz, Yasmina Gossmann, Silke Redler, Bettina Blaumeiser, Gerhard Lutz, Ulrike Blume‐Peytavi, Markus M. Nöthen, Regina C. Betz, F. Buket Basmanav   +9 more
wiley   +1 more source

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial

Allergy, EarlyView.
Different functions of an allergy app were tested for clinical benefit in a randomized, controlled trial in patients with grass pollen allergy. Participants with pollen forecast function took more medication and had fewer symptoms than participants without pollen forecast. A symptom forecast was developed based on the study data.
Caroline Holzmann, Johannes Karg, Matthias Reiger, Rajiv Kharbal, Paola Romano, Sabrina Scheiwein, Claudia Khalfi, Anna Muzalyova, Jens O. Brunner, Gertrud Hammel, Athanasios Damialis, Claudia Traidl‐Hoffmann, María P. Plaza, Stefanie Gilles   +13 more
wiley   +1 more source

Stratum Corneum Interleukin‐2 in Facial Eczema at 1‐Month‐Old Predicts Later Atopic Dermatitis

Allergy, EarlyView.
Eriko Maehara, Makiko Kido‐Nakahara, Yasuyuki Fujita, Kiyoko Kato, Saki Kido, Ryo Yamasaki, Satoshi Nagata, Junji Kishimoto, Hiroko Watanabe, Eri Harada, Yumiko Nagashima, Eisuke Umeno, Gaku Tsuji, Hitokazu Esaki, Takeshi Nakahara   +14 more
wiley   +1 more source

Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross‐Reactivity and Reintroduction in Chinese Population

Allergy, EarlyView.
Clinical history including self‐reported history and oral food challenge outcome, and sIgE sensitization profile of 200 subjects with suspected fish allergy was analyzed to construct a 3‐step fish allergenicity ladder. The allergenicity ladder was positively linked to the relative parvalbumin content of fish muscle but not to differences in the IgE ...
Christine Y. Y. Wai, Nicki Y. H. Leung, Agnes S. Y. Leung, Man Fung Tang, Åsa Marknell DeWitt, Jaime S. Rosa Duque, Gilbert T. Chua, Yat Sun Yau, Wai Hung Chan, Po Ki Ho, Mike Y. W. Kwan, Qun Ui Lee, Joshua S. C. Wong, Ivan C. S. Lam, James W. C. H. Cheng, David C. K. Luk, Zhongyi Liu, Noelle Anne Ngai, Oi Man Chan, Patrick S. C. Leung, Gary W. K. Wong, Ting Fan Leung   +21 more
wiley   +1 more source